Coptis chinensis Extract Inhibits the Production of Inflammatory Mediators and Delayed Type Hypersensitivity in Mice
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Coptis chinensis rhizome has been used as a medicinal herb in traditional Oriental medicine. We investigated the effects of Coptis chinensis extract on inflammatory mediators and delayed type hypersensitivity in mice. Methods: The inhibitory effect of ethanolic extract of Coptis chinensis (CCE) on cell proliferation was evaluated using MTS assay. The lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages and the Con A-activated mouse splenocytes were cultured with various concentrations of CCE. Total nitric oxide (NO) production was determined by Griess reaction. The amounts of secreted prostaglandine E2 (PGE2), interleukin (IL)-2 and IFN-γ were measured by ELISA. To investigate the in vivo anti-inflammatory effect of CCE, oxazolone-induced delayed type hypersensitivity (DTH) model was used. Results: The CCE at 100 μg/ml significantly blocked the LPS-induced production of pro-inflammatory mediators (NO and PGE) in RAW264.7 macrophages. Also, it significantly inhibited cell proliferation and cytoine (IL-2 and IFN-γ) production in splenocytes. Furthermore, when splenocytes from CCE fed mice (200 mg/kg for 2 weeks) were activated with Con A, cell proliferation and cytokine production were significantly inhibited. In addition, CCE decreased in vivo inflammation in oxazolone-induced DTH model mice. Conclusion: We suggest that Coptis chinensis can be used as an anti-inflammatory drug by exerting an inhibitory effect in inflammatory mediator- and cell-mediated inflammation.
Abstract
Background: Coptis chinensis rhizome has been used as a medicinal herb in traditional Oriental medicine. We investigated the effects of Coptis chinensis extract on inflammatory mediators and delayed type hypersensitivity in mice. Methods: The inhibitory effect of ethanolic extract of Coptis chinensis (CCE) on cell proliferation was evaluated using MTS assay. The lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages and the Con A-activated mouse splenocytes were cultured with various concentrations of CCE. Total nitric oxide (NO) production was determined by Griess reaction. The amounts of secreted prostaglandine E2 (PGE2), interleukin (IL)-2 and IFN-γ were measured by ELISA. To investigate the in vivo anti-inflammatory effect of CCE, oxazolone-induced delayed type hypersensitivity (DTH) model was used. Results: The CCE at 100 μg/ml significantly blocked the LPS-induced production of pro-inflammatory mediators (NO and PGE) in RAW264.7 macrophages. Also, it significantly inhibited cell proliferation and cytoine (IL-2 and IFN-γ) production in splenocytes. Furthermore, when splenocytes from CCE fed mice (200 mg/kg for 2 weeks) were activated with Con A, cell proliferation and cytokine production were significantly inhibited. In addition, CCE decreased in vivo inflammation in oxazolone-induced DTH model mice. Conclusion: We suggest that Coptis chinensis can be used as an anti-inflammatory drug by exerting an inhibitory effect in inflammatory mediator- and cell-mediated inflammation.
참고문헌 (27)
- Wu MJ, "Glossogyne tenuifolia acts to inhibit inflammatory mediator production in a macrophage cell line by downregulating LPS-induced NF-Kb", J Biomed Sci, 11, pp.186~199 (2004)
- Dinarello CA, "Interleukin-1, interleukin-1 receptors and interlekin-1 receptor antagonist", Int Rev Immunol, 16, pp.457~499 (1998)
- Nathan C, "Natural resistance and nitric oxide", Cell, 82, pp.873~876 (1995)
- Fenton MJ, "LPS-binding proteins and receptors", J Leukoc Biol, 64, pp.25~32 (1998)
- Glauser MP, "The inflammatory cytokines. New developments in the pathophysiology and treatment of septic shock", Drugs, 52, pp.9~17 (1996)
- Duan H, "Effect of anemonin on NO, ET-1 and ICAM-1 production in rat intestinal microvascular endothelial cells", Journal of Ethnopharmacology, 104, pp.362~366 (2006)
- Lefkowith JB, "Cyclooxygenase-2 specificity and its clinical implications", American Journal of Medicine, 106, pp.43S~50S (1999)
- Solomon SD, "Cyclooxygenase-2 inhibitors and cardiovascular risk", Curr Opin Cardiol, 21, pp.613~617 (2006)
- Ikram M, "A review on the chemical and pharmacological aspects of genus Berberis", Planta Med, 28, pp.353~358 (1975)
- Schmeller T, "Biochemical activities of berberine, palmaltine and sanguinarine mediating chemical defense against microorganisms and herbivores", Phytochemistry, 44, pp.257~266 (1997)
- Kettmann V, "In vitro cytotoxicity of berberine against HeLa and L1210 cancer cell lines", Pharmazie, 59, pp.548~551 (2004)
- Kuo CL, "The anti-inflammatory potential of berberine in vitro and in vivo", Cancer Lett, 20, pp.127~137 (2004)
- Pathak N, "Oxidative stress and apoptotic changes in murine splenocytes exposed to cadmium", Toxicology, 220, pp.26~36 (2006)
- Blaylock BL, "Topical exposure to chlordane reduces the contact hypersensitivity response to oxazolone in BALB", c mice, 1995, pp.81, 205~211
- Mayer B, "Biosynthesis and action of nitric oxide in mammalian cells", Trends Biochem Sci, 22, pp.477~481 (1997)
- Nathan C, "Nitric oxide as a secretory product of mammalian cells", FASEB J, 6, pp.3051~3064 (1992)
- Akarasereenont P, "Cytokine-mediated induction of cyclo-oxygenase 2 by activation of tyrosine kinase in bovine endothelial cells stimulated by bacterial lipopolysaccharide", Br J Pharmacol, 115, pp.401~408 (1994)
- Rothenberg EV, "IL-2 gene inducibility in T cells before T cell receptor expression. Changes in signaling pathways and gene expression requirements during intrathymic maturation", The Journal of Immunology, 144, pp.1614~1624 (1990)
- Szabo SJ, "A novel transcription factor, T-bet, directs Th1 lineage commitment", Cell, 100, pp.655~669 (2000)
- Mullen AC, "Role of T-bet in commitment of Th1 cells before IL-12-depedent selection", Science, 292, pp.1907~1910 (2001)
- Schwartz RH, "Natural regulatory T cells and self-tolerance", Nature Immunology, 6, pp.327~330 (2005)
- Verdrngh M, "Genistein as an anti-inflammatory agent", Inflammation Research, 52, pp.341~346 (2003)
- Yasukawa K, "Relative inhibitory activity of berberine-type alkaloids against 12-O-tetra decanoylphorbol-13- acetate-induced inflammation in mice", Chem Pharm Bull, 39, pp.1462~1465 (1991)
- Fukuda K, "Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells", J Ethnopharmacol, 66, pp.227~233 (1999)
- Lee DU, "Effects of 13-alkylsubstituted berberine alkaloids on the expression of COX-II, TNF-a, iNOS, and IL-12 production in LPS stimulated macrophages", Life Sci, 73, pp.1401~1412 (2003)
- Li B, "Study of total alkaloids from Rhizoma Coptis Chinensis on experimental gastric ulcers", Chin J Integr Med, 11, pp.217~221 (2005)
- Liang KW, "Berberine suppresses MEK", ERK-dependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injury, 2006, pp.71, 806~817